Draft:Austin Yeargan III

Austin Yeargan III MD is an orthopedic surgeon who specializes in orthopedic surgical immunobiologic treatments. Dr. Yeargan practices medicine in Wilmington, NC, where he offers convention and traditional orthopedic surgical management strategies and modern immunobiologic techniques that he introduced to the field of orthopedic surgery as early as 2006. Building on the work of Philippe Hernigou MD, a french surgeon who offered the techniques originally in Europe and under the tutelage of NC orthopedic surgeon Dan Eglinton MD, doctor Yeargan expanded the field of knowledge and engineered clinical protocols to enhance patient treatments and shorten recovery times. Doctors Eglinton and Yeargan focused on cell signaling pathways and nanomolecular interactions at the cell level to produce clinical algorithms for knee osteoarthritis and partial thickness rotator cuff tears. The pair introduced combining autologous bone marrow concentrate and platelet rich plasma growth factor concentrates with traditional surgical procedures in 2006. Initially ridiculed for their novel approaches, the pair persisted with their advanced work and pushed additional iterations of the treatment algorithms to get the field of 'orthopedic regenerative medicine' to the success it enjoys today. Doctor Yeargan was the first orthopedic surgeon in the US to offer orthopedic immunobiologics in the office setting. His initial work with Celling Biosciences in Austin, Texas can be credited to the genesis of orthopedic immunobiologics and the expansion of the field today. Today there are over 2000 clinics in the US offering some version of his early brainchild.

Doctor Yeargan went to Saint David's Episcopal school in Raleigh where he first became interested in Chemistry thanks to the efforts of Dorothy LaFave. He completed his studies early, allowing him to spend 12 months in Queensland, Australia. On returning to the US, he went on to study chemistry at the University of North Carolina, Chapel Hill. He attended medical school at the East Carolina University Brody School of medicine, finishing in 1997. He matched in general surgery at the University of Hawaii. While on an orthopedic surgery rotation during his intern year, following the advice and guidance of Allen B Richardson MD, son of Hawaii's first orthopedic surgeon, he found his passion. Following orthopedic surgery residency at the University of Hawaii, he matched into the renowned Steadman-Hawkins Sports Medicine Fellowship program in Vail, Colorado where he worked with Richard Hawkins MD, Richard Steadman MD, Bill Sterrett MD and Randy Viola MD.

Dr. Yeargan began his orthopedic surgery career in San Luis Obispo, California but returned to his home state of North Carolina after just one year in 2006. Dr. Yeargan became friends with Dr. Dan Eglinton through Dr. Eglinton's son, Jeff who supplied the total shoulder replacement and total knee devices Dr. Yeargan was using for joint replacement surgery. The two hit it off right away because, like Dr. Yeargan, Dr. Eglinton was convinced of the power of orthopedic immunobiologics as potential treatment options in the setting of joint diseases like arthritis. It was through Dr. Eglinton that Dr. Yeargan met with and became involved with research and development with Celling Biosciences in Austin, Texas.

In 2006, Dr. Yeargan developed and wrote the first clinical protocols in the nation for orthopedic immunobiologics like platelet rich plasma (PRP) and autologous bone marrow concentrates(ABMAC) using the Celling ART devices for concentrating peripheral blood platelets and autologous bone marrow cell therapy. Dr. Yeargan introduced the field of orthopedics to these techniques and was the first orthopedic surgeon in the country to offer autologous bone marrow concentrates(ABMAC) in the clinical setting. His early work involved the clinical application to partial thickness rotator cuff tears and glenohumeral knee and hip arthritis. He is also known for introducing surgical applications to rotator cuff repairs and musculotendinous sports injuries.

Dr. Yeargan's contributions to the field remain relevant today and he has written numerous articles in collaboration with his collesagues that are published in the orthopedic literature. These articles enjoy widespread readership from multiple fields and his work appeals to a broad range of clinical scientist practitioners all over the world. Today, Dr. Yeargan's autologous bone marrow concentrate transplant nanoplasty is sought after for the clinical facility of the procedure and the demonstrated clinical efficacy of the eighth iteration of the procedure since inception. Doctor Yeargan is one of the most experienced orthopedic surgeons in the nation who offers autologous bone marrow translant procedures and platelet rich plasma procedures that he more appropriately terms, "Signaling cell procedures" and "Growth Factor Concentrate" procedures, recognizing the pioneering scientific work of the late Arthur L Kaplan PhD.

Doctor Yeargan lives in Wilmington, North Carolina and is still in active practice at the Carolina Joint and Arthritis Clinic.